المؤلفون: K. S. Savchuk, К. С. Савчук

المصدر: Medical Immunology (Russia); Том 25, № 4 (2023); 797-802 ; Медицинская иммунология; Том 25, № 4 (2023); 797-802 ; 2313-741X ; 1563-0625

مصطلحات موضوعية: иммунная дизрегуляция, natural killers, long-COVID, impaired glucose tolerance, diabetes mellitus type 2, immune dysregulation, натуральные киллеры, постковидный синдром, нарушенная толерантность к глюкозе, сахарный диабет 2 типа

وصف الملف: application/pdf

العلاقة: https://www.mimmun.ru/mimmun/article/view/2848/1721Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2848/12046Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2848/12047Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2848/12048Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2848/12050Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2848/12457Test; Dobrynina M.A., Zurochka A.V., Komelkova M.V., Shanshan L. Impairment of natural killer populations in the patients recovered from COVID-19. Russian Journal of Immunology, 2022, Vol. 25, no. 2, pp. 161-166. (In Russ.); Galán M., Vigón L., Fuertes D., Murciano-Antón M., Casado-Fernández G. Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: Identification of Diagnostic Biomarkers. Front. Immunol., 2022, Vol. 13, 848886. doi:10.3389/fimmu.2022.848886.; Salukhov V.V., Minakov A.A., Sharypova T.G., Alena A. Kononova A.A. Carbohydrate metabolism disorders and their outcomes in the long-term period in hospitalized patients with COVID-19. Diabetes Mellitus, 2022, Vol. 25, no. 5, pp. 468-476. (In Russ.); Savchenko A.A., Kudryavtsev I.V., Isakov D.V., Sadowski I.S. Recombinant human interleukin-2 corrects NK cell phenotype and functional activity in patients with post-COVID syndrome. Pharmaceuticals, 2023, Vol. 16, 537. doi:10.3390/ph16040537.; Soleimanian S., Yaghobi R. Harnessing memory NK cell to protect against COVID-19. Front. Pharmacol., 2020, Vol. 11, 1309. doi:10.3389/fphar.2020.01309.; Zurochka A.V., Khaidukov S.V., Kudryavtsev I.V., Chereshnev V.A. Flow cytometry in biomedical research. Ekaterinburg: RIO UB RAS, 2018, 720 p; https://www.mimmun.ru/mimmun/article/view/2848Test

الإتاحة: https://doi.org/10.15789/1563-0625-COT-2848Test
https://doi.org/10.3389/fimmu.2022.848886Test
https://doi.org/10.3390/ph16040537Test
https://doi.org/10.3389/fphar.2020.01309Test
https://www.mimmun.ru/mimmun/article/view/2848Test

المؤلفون: I. V. Kologrivova, T. E. Suslova, O. A. Koshelskaya, I. V. Vinnizkaya, O. A. Trubacheva, N. M. Zheltonogova, A. M. Gusakova, И. В. Кологривова, Т. Е. Суслова, О. А. Кошельская, И. В. Винницкая, О. А. Трубачева, Н. М. Желтоногова, А. М. Гусакова

المصدر: Medical Immunology (Russia); Том 15, № 2 (2013); 155-162 ; Медицинская иммунология; Том 15, № 2 (2013); 155-162 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2013-2

مصطلحات موضوعية: нарушение толерантности к углеводам, FoxP3+T-regulatory lymphocytes, diabetes mellitus type 2, impaired glucose tolerance, FoxP3+Т-регуляторные лимфоциты, сахарный диабет 2-го типа

وصف الملف: application/pdf

العلاقة: https://www.mimmun.ru/mimmun/article/view/106/107Test; Дедкова А.А., Суслова Т.Е., Кологривова И.В., Баталов Р.Е., Антонченко И.В., Попов С.В. Факторы воспаления и маркеры повреждения миокарда при фибрилляции предсердий // Вестник аритмологии. – 2010. – № 60. – С. 49-53. Dedkova A.A., Suslova T.E., Kologrivova I.V., Batalov R.E., Antonchenko I.V., Popov S.V. Faktory vospaleniya i markery povrezhdeniya miokarda pri fibrillyatsii predserdiy [Factors of inflammation and myocardial injury during atrial fibrillation]. Vestnik aritmologii – Bulletin of Arrhythmology, 2010, no. 60, pp. 49-53.; Рунихин А.Ю., Новикова Ю.В. Современные аспекты патогенеза и лечения сахарного диабета 2 типа // Русский медицинский журнал. Эндокринология. – 2007. – Т. 15, № 27. – С. 2060-2066. Runikhin A.Yu., Novikova Yu.V. Sovremennye aspekty patogeneza i lecheniya sakharnogo diabeta 2 tipa [Modern aspects of the pathogenesis and treatment of type 2 diabetes]. Russkiy meditsinskiy zhurnal Endokrinologiya – Russian Medical Journal Endocrinology, 2007, vol. 15, no. 27, pp. 2060-2066.; Basta G., Schmidt A.M., De Caterin R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research, 2004, vol. 63, pp. 582-592.; Betteridge D.J. Lipid control in patients with diabetes mellitus. Nature Reviews Cardiology, 2011, vol. 8, pp. 278-290.; Caforio, A.L., Mahon N.J. Circulating cardiac antibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur. J. Heart, 2002, vol. 4, pp. 411-417.; Chung C.P., Oeser A., Solus J.F., Gebretsadik T., Shintani A., Avalos I., Sokka T., Raggi P., Pincus T. Stein C.M. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupuis erythematosus define potential mechanisms. Arthritis Rheum., 2008, vol. 58, no. 7, pp. 2105-2112.; Flisiak R., Pelszynska M., Prokopowicz D., Rogalska M., Grygoruk U. High concentration of antimitochondrial antibodies predicts progressive primary biliary cirrhosis. World J. Gastroenterol., 2005, vol. 11, no. 36, pp. 5706-5709.; Fowler M.J. Microvascular and macrovascular complications of diabetes. Clinical Diabetes, 2008, vol. 26, no. 2, pp. 77-82.; Jagannathan-Bogdan M., McDonnel M.E., Liang Y., Hasturk H., Hetzel J., Rubin D., Kantarci A., Van Dyke T.E., Ganley-Leal L.M., Nikolajczyk B.S. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia, 2010, vol. 53, no. 7, pp. 1461-1471.; Jagannathan-Bogdan M., McDonnell M.E., Shin H., Rehman Q., Hasturk H., Apovian C.M., Nikolajczyk B.S. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J. Immunol., 2011, vol. 186, pp. 1162-1172; Leaungwutiwong P., Ittiprasert W., Saikhun K., Tong-Ngam P., Akapirat S., Chattanadee S., Kitiyanant Y. Impairment of CD4+CD25+ regulatory T cells in C4-deficient mice. Asia Pac. J. Allergy Immunol., 2011, vol. 29, no. 3, pp. 220-228.; Leslie D., Lipsky P., Notkins A.L. Autoantibodies as predictors of disease. J. Clin. Invest., 2001, vol. 108, no. 10, pp. 1417-1422.; Moscatiello S., Manini R., Marchesini G. Diabetes and liver disease: an ominous association. Nutrition, Metabolism and Cardiovascular Diseases, 2007, vol. 17, pp. 63-70.; Newkirk M.M., Goldbach-Mansky R., Lee J., Hoxworth J., McCoy A., Yarboro C., Klippel J., El-Gabalawy H.S. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res. Ther., 2003, vol. 5, no. 2, pp. r82-r90.; Ovsenyan M., Boyadjan A.S., Maltkonyan A.A., Gevorkyan A.A. Circulating immune complexes at the late stages of diabetes mellitus. Immunology, 2004, vol. 25, pp. 375-377.; Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell, 2008, vol. 133, pp. 775-787.; Shamshiev A.T., Ampenberger F., Ernst B., Rohrer L., Marsland B.J., Kopf M. Dyslipidemia inhibits Toll-like receptor-induced activation of CD8 alpha-negative dendritic cells and protective Th1 type immunity. J. Exp. Med., 2007, vol. 204, no. 2, pp. 441-452.; Sohna Chandra Packiavathy A., Ramalingam M. Evaluation of haemotological and immunological status in type 2 diabetes. E-Journal of Chemistry, 2010, vol. 7, no. 3, pp. 1029-1032.; Umpaichitra V., Banerji M.A., Castells S. Autoantibodies in children with type 2 diabetes mellitus. J. Pediatr. Endocrinol. Metab., 2002, vol. 15, suppl. 1, pp. 525-530.; Van de Weijer T., Schrauwen-Hinderling V.B., Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc. Res., 2011, vol. 92, no. 1, pp. 10-18.; Zeng C., Shi X., Zhang B., Liu H., Zhang L., Ding W., Zhao Y. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J. Mol. Med., 2012, vol. 90, no. 2, pp. 175-186.; Zhang W., Sharma R., Ju S., He X.S., Tao Y., Tsuneyama K., Tian Z., Lian Z.X., Fu S.M., Gershwin M.E. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology, 2009, vol. 49, no. 2, pp. 545-552.; https://www.mimmun.ru/mimmun/article/view/106Test

الإتاحة: https://doi.org/10.15789/1563-0625-2013Test-2-155-162
https://doi.org/10.15789/1563-0625-2013Test-2
https://www.mimmun.ru/mimmun/article/view/106Test